Norlase has opened a new key position; Quality Engineer. This new member of our team will be responsible for implementing and maintaining key quality processes, as we scale our production of medical lasers. This person will work closely with and report to the VP of QA & RA, as the Quality ambassador in our production area.
The ideal candidate has at least 3 years of experience within Quality Assurance work in a medical industry company, preferably from medical device production regulated by ISO 13485 or FDA QSR part 820.
To read more about the position and apply, follow this link.
Norlase is pleased to announce that Oliver Hvidt has been appointed as our new Chief Executive Officer (CEO), effective immediately. Previous CEO Peter M. W. Skovgaard remains part of the senior management team and is the new Chief Operating Officer (COO).
Mr. Hvidt and Dr. Skovgaard are co-founders of Norlase and have worked in close concert since the early stages of the Company. This partnership is set to continue, as Dr. Skovgaard remains fully committed to Norlase in his new management role.
Norlase Chairman David Hardwick issued the following statement: “During his tenure as CEO, Peter has successfully steered our company through several years of challenging technology development. I wholeheartedly congratulate Peter on this achievement and thank him for his continued service as our new COO. Both Peter and the Board of Directors are excited to see Oliver step into the CEO role. Oliver has a long track-record with Norlase and his strong background in business development and marketing will serve our company well.”
For more information, reach out to email@example.com
The mayor of Ballerup, Jesper Würtzen, visited Norlase to learn more about what makes the Copenhagen suburb an attractive location.
“Ballerup was the obvious choice for our company” explains Norlase CEO Peter M. W. Skovgaard. “It has close proximity to the city of Copenhagen and the Technical University of Denmark and the associated talent pools. There is also a high concentration of high-tech and med-tech companies in the area, which creates a lot of synergy. Just across the street is another growth company working with new laser technology for medical applications” Mr. Skovgaard states, referring to Advalight, a manufacturer of dermatology laser equipment and neighbor to Norlase.
“Finally, we were able to find facilities that met all our needs for office space, manufacturing and laboratories, including clean-rooms. It’s rare to find that combination in one location.”
After the meeting, Mayor Würtzen received a tour of the facilities and a sneak-peak at some of Norlase’s upcoming projects. Norlase looks forward to continuing our engagement in the local business community.
Norlase CEO Peter M. W. Skovgaard was invited to present at the 2018 EuroTech High Level Event in Brussels. The event gathered members from the European Commission, leaders from Europe’s top universities and succesful technology start-ups.
The goal was to share experiences and ideas for modernizing how entrepreneurship and innovation is funded within the EU.
Peter Skovgaard explained how the right mix of public and private funding enabled Norlase’s journey from university lab to growing high-tech start-up.
Norlase is hiring a production engineer, who will be responsible for developing, managing and scaling the production of our break-through medical laser products. This person will our primary expert within manufacturing and will have a key role in both the day-to-day operations and long-term future development of Norlase.
If you dream of being a part of the next generation in medical laser devices, and to be able to make a difference within break-through laser technology, which will disrupt the market, this might be your perfect opportunity.
The recruiting process for this position is handled in collaboration with headhunting and recruiting agency Profilpartners. To read more about the position and apply, please visit Profilpartners here.
Norlase is looking for a part-time office manager and book-keeper. This role will be important for our day-to-day operations and you will be working closely with the entire Norlase team. Your responsibilities will be very diverse, but book-keeping and accounting will be key.
If you have experience with accounting and a drive for being an important part of passionate team, you could be the person we are looking for. To see the full job posting and apply, click here.
This year’s CLEO conference will feature a topical review of Scientific and Commercial Progress in Semiconductor Laser Technology. Norlase’s founder and CEO, Peter M. W. Skovgaard, is invited to give a talk on recent developments in the field.
The talk will focus on the latest breakthroughs and challenges for high-power, semiconductor-based lasers in the yellow wavelength region. He will present the first multi-watt level 577 nm laser based on tapered semiconductor diodes.
CLEO is the world’s premier forum for optical science and technology. It takes place in Silicon Valley, in the San Jose Convention Center, from May 13 – 18. Mr. Skovgaard’s talk is Friday, May 18 at 8 am. For more information, see the CLEO homepage: www.cleoconference.org.
Norlase has finally completed the move to our new headquarters at Brydehusvej 30 in Ballerup, Denmark.
This 500 sqm facility marks a new chapter for our company. With multiple clean rooms and state-of-the-art equipment, it enables us to scale production of high-power visible lasers, while maintaining our strong R&D efforts. We also aim to squeeze in a foosball table.
The move means that Norlase will no longer rely on the Technical University of Denmark (DTU) for laboratory or office space. We owe a debt of gratitude to the DTU researchers and staff, who created the environment for Norlase to grow to this stage. We look forward to continuing our close partnership with DTU, including several joint innovation projects.
The official opening will be June 15, where we hope to see our friends and partners at the housewarming party. You can read more about this event and register here: https://laser-housewarming.eventbrite.com
During the world’s leading photonics conference, Norlase will give a talk on a new breakthrough: a high-power, 577 nm “true yellow” laser. The laser is based on our proprietary AuroraOne technology and shares the advantages of the AuroraOne product family: near diffraction-limited beam, compact size, low cooling need and watt-level power.
“The recent results show the potential of the AuroraOne technology” says Norlase CEO Peter M. W. Skovgaard. “It is not only about cost-efficiency and high quality, but also about flexibly providing wavelengths that are normally very challenging. This has already been demonstrated with our 488 and 561 nm products and the true yellow laser is another step forward”.
Industrial PhD student Mathias Christensen (pictured above, to the left) has been instrumental in the development. He is the lead author of the associated publication and will give the presentation at the conference. The presentation is in session 10516 on Nonlinear Frequency Generation on January 29 at 8:40 am, in room 311.
Will you attend Photonics West 2018? Want to know more about true yellow lasers or the AuroraOne product family? Please don’t hesitate to reach out to Norlase at firstname.lastname@example.org.
The development of the 577 nm laser was made possible through collaboration with our partners at eagleyard Photonics GmbH, the Technical University of Denmark and the Ferdinand-Braun-Institut. It is part of project “CODIS” under the European Union’s Horizon 2020 programme, which aims to introduce a new generation of lasers for ophthalmology and other medical applications.
Norlase is expanding the engineering team with a key position. As our mechanical engineer, you will play a crucial part in developing our next-generation laser-based medical devices. You will be heading development efforts within highly precise mechanical user-interfaces, design of compact housing and mounting solutions, as well as manufacturability of current and future products.
Norlase is a fast-paced high-tech start-up, poised to disrupt a large market segment. If you have the required experience and are motivated by joining us on this journey, we encourage you to apply before the deadline on December 21. To see the full job post and list of requirements, click here.
Norlase is looking to fill a key role for the next stage of our journey: Vice President of Quality Assurance and Regulatory Affairs. This person will be responsible for regulatory approval of our medical laser products and will be essential in building a quality-centered organization, as we continue to grow.
If you have QA & RA experience and are motivated by building a global high-tech company from the early stage, you might be exactly who we are looking for. Application deadline October 30, 2017. To see the full job post click here.
Will you be attending the World of Photonics Trade Fair in Munich from June 26 – 29? If so, we invite you to stop by Booth 625 (Hall B1) for a first-hand look at the AuroraOne family of next-generation visible sources that enable more convenient, effective and cost-efficient systems.
While at the event, don’t miss the Norlase presentation during “Space meets LASER World of PHOTONICS”, part of the Start-up World Program on Wednesday afternoon:
To schedule an appointment with us during World of Photonics, or to learn more about Norlase’s products and demo program, feel free to reach out at email@example.com.
Looking forward to seeing you in Munich, or hearing from you about your laser application!
Norlase is hiring a Postdoc within high-power semiconductor lasers. The position offers a unique combination of academic and entrepreneurial experience, within Denmark’s leading photonics start-up.
In addition to holding a Ph.D. in laser physics or technology, you must have been located outside of Denmark for the past 3 years – and have a taste for adventure. To see the full vacancy notice, click here.
Feeling uninspired by ordinary, everyday lasers? Norlase is ‘Making Lasers Great Again’! and we will be at Photonics West 2017 to prove it. Stop by Booth 5069 (North Hall) for a first-hand look at the AuroraOne family of next-generation visible sources that enable more convenient, effective and cost-efficient systems.
While at the conference, don’t miss technical presentations about our latest innovations in performance and wavelengths during the LASE technical program on Monday, January 30 (papers 10088-1 and 10088-2) and Tuesday, January 31 (paper 10088-44).
To schedule an appointment with us during Photonics West, or to learn more about Norlase’s products, feel free to reach out at firstname.lastname@example.org.
We are proud to announce that Norlase will receive funding from the European Commission under the EU Horizon 2020 SME instrument.
Project CoDiS (Compact, high-power, frequency-converted Diode laser Systems) will accelerate the development of Norlase lasers for medical use and in the yellow wavelength region. This will enable more affordable and accessible treatment of diabetic eye disease and other medical conditions.
Diode laser manufacturer Eagleyard (GE) is a partner in the project, while the Ferdinand-Braun-Institut (GE) is a key sub-contractor.
Leading Danish business newspaper Børsen brings this article on the funding and the opportunity to improve laser medical treatments worldwide (Danish only):
More information about the project can also be found on the EU’s Community Research and Development Information Service:
For more information about Horizon 2020 and the SME instrument, see:
For the latest updates on project CoDiS, do not hesitate to reach out to Norlase at email@example.com.
Norlase is about to embark on the next stage of our mission to revolutionize medical laser markets. This opens a key R&D engineering position in our company.
Are you motivated by taking on big technological challenges as part of a passionate team? Are you ready to join Demarks leading photonics start-up? Then you might be our new Laser R&D Engineer.
To see the full job post click here.
We are happy to announce two major innovation projects that will receive funding from the European Commission under the Eurostars programme. Eurostars focuses on international projects that result in fast market introduction of innovative products.
Project ViDiLas will utilize the unique Norlase laser technology to create a more cost-effective and compact eye-treatment system. The goal is to enable more accessible and effective treatment for over 500 million people suffering from age- and diabetes-related eye diseases. The consortium around ViDiLas includes laser medical device manufacturer Pantec (CH), tapered diode manufacturer Eagleyard (GE) and the light source research institution Ferdinand Braun Institut (GE).
Project GENESIS focuses on bringing the advantages of laser microscopy out of the lab and into point-of-care diagnostics. Norlase’s laser technology enables far more compact and cost-effective Ti:Sapphire laser systems, which in turn enables extremely precise and effective diagnosis through e.g. raman spectroscopy and light sheet microscopy. The project is carried out in collaboration with leading Ti:Sapphire laser manufacturer M Squared Lasers (GB) and the Technical University of Denmark, Department of Photonics (DK).
According to the Danish Eurostars Officer, Jens Peter Vittrup, Norlase’s success in the Eurostars programme is unheard of. “Both of Norlase’s projects were ranked in the international top 10, which has never happened for a Danish company before”, he states. “This result should to be seen in the context that over 300 applications were filed”.
For more on Norlase and Eurostars, check out this recent article on Danish startup media trendsonline: http://trendsonline.dk/2016/04/29/laser-virksomheden-norlase-opnar-stotte-til-hele-projekter-fra-eurostars/ (Danish only)
Visit Norlase at Photonics West 2016, to witness the world-premiere of the 561 nm Norlase AuroraOne laser. The newest member of the AuroraOne family offers new levels of convenience and the lowest cost-of-ownership for powerful, high-quality yellow-green lasers. It delivers up to 2 W of output power with M2 < 1.2 and modulation capability – all in a compact, air-cooled package. This enables manufacturers of medical laser equipment to design more convenient, effective and cost-efficient systems.
Norlase exhibits at Photonics West, the world’s #1 laser conference, which takes place in San Francisco’s Moscone Center from 16th – 18th of February 2016. Come by booth 5070 to hear more about the award-winning AuroraOne family of lasers and our mission to deliver truly convenient visible lasers. To learn about our exhibition and availability at Photonics West, feel free to reach out at firstname.lastname@example.org
When the world’s # 1 laser conference opens its doors in 2016, it will be with Norlase among the exhibitors. Photonics West 2016 takes place in San Francisco’s Moscone Center from 16th – 18th of February. For the first time ever, more than 20.000 conference attendees will have the chance to visit Norlase at booth #5070 and have a closer look at our products.
In addition to the friendly Norlase staff, the booth will feature live demonstrations of the award-winning AuroraOne family of lasers. AuroraOne brings unprecedented cost-effectiveness and flexibility to medical and bio-imaging applications – so come by booth 5070 to learn more about the next generation of visible lasers. To learn about our exhibition and availability at Photonics West, feel free to reach out at email@example.com
Our technology encompasses the best of two worlds: The starting point is a strong and not least future-oriented technology. In addition, we are financially competitive as our laser is easy to produce and less expensive than competing products while also being highly efficient,” says Peter Skovgaard.
Follow the Link to watch CEO Peter Skovgaard and co-inventor Paul Michael Petersen talk about Norlase.
Holography News® ‘caught up’ with Nicklas Jarnel (Business Developer) and Dr Michelle Stock (Director of Business Development) from Norlase following the 10th International Symposium on Display Holography in St Petersburg, in July, where Norlase’s technology and future developments were presented.
Find the full article: Link
Norlase has recieved signficant financial support from the Danish Market Development Fund. The grant supports the development project COTIS (Compact TI:Sapphire laser system), with the aim of optimizing Norlase’s AuroraOne laser for pumping of laser systems for medical imaging and research. COTIS will be carried out in collaboration with femtosecond laser system manufacturer Femtolasers, medical device manufacturer Jenlab and the Technical University of Denmark.
The purpose of the Market Development Fund is to promote growth, employment and exports, particularly for small and medium-sized enterprises in areas where Denmark has particular strength and potential. Such areas include conversion to green technology, health and welfare solutions, design and other creative professions, etc.
“The most valuable part of this project, is the close collaboration with customers and end-users for our product. It helps us maximize the value we can create with AuroraOne” – Peter M.W. Skovgaard, CEO, Norlase
More details about the project can be found on the Market Devlopment Fund’s webpage (in danish)
At the World of Photonics conference in Munich, Norlase participated in the first edition of the Startup World Competition. The competition promotes the most promising new companies in the laser industry, which Norlase finished at an honourable 2nd place. If you want to learn more about Norlase, click the picture on your right, to see an interview from Munich with business developer Oliver Hvidt, explaining the technology.
After a successful conference, we at Norlase, would like to thank everyone we met and everyone who had time to visit our booth. If you would like to contact us, please do so at firstname.lastname@example.org
Norlase will be exhibiting in Munich at the World of Photonics conference from the 22nd to the 26th of June, in hall 3B, booth 528. Come meet us at our booth to learn more about our technology and to see our groundbreaking AuroraOne laser.
Norlase is nominated as one of 3 finalists in the first edition of The Startup World. Come meet us at the Award Ceremony, starting Wednesday 10:30 in hall A2 at the Optical Meteorology & Imaging Forum. At The Startup World Norlase will be pitching Wednesday at 14:20 and Thursday 10:20 in hall 3B at The Startup World Forum
For meeting-requests at the conference, please contact Nicklas Jarnel at email@example.com
Norlase is proud to announce that AuroraOne, our ultra-low noise visible laser, is the winner of the Technology Transfer Program at CLEO 2015.
CLEO is the world’s leading peer-reviewed meeting on photonics and the premier international forum for laser science and industry. Despite strong competition, Director of Business Development, Michelle L. Stock’s pitch won the prize as the best new technology at the 2015 Pitch Panel. To learn more about the benefits of the AuroraOne laser, contact us at firstname.lastname@example.org.
Norlase is currently exhibiting their ultra-compact AuroraOne laser, for the first time publically, at the CLEO conference in San Jose, California. The AuroraOne delivers high-brightness and low noise in wavelenghts such as 465, 488, 515 and 532nm, making it ideal for applications such as microscopy, high-throughput DNA sequencing and holography. Norlase is exhibiting at booth 2512 – come by to learn more.
At Thursday 14th of May, Director of Business Development at Norlase, Michelle L. Stock, will be presenting the Norlase technology, as part of the pitch panel at the Technology Transfer Program from 9:30-12:30 in the Exhibit Hall Theater(the pitch panel runs from 10:45-12.30). Come by to hear about Norlase’s revolutionizing technology.
CEO Peter Skovgaard will lead the Norlase delegation heading to the Photonics West conference from the 6th to the 13th of February.
The conference takes place in San Francisco, CA, being the years biggest industry event. We look forward to meeting our current and potential future partners in this inspiring setting.
Is your company also attending Photonics West? If you are interested in hearing more about the next generation of ultra-compact, high perfomance lasers, please contact Nicklas Jarnel at email@example.com for more about our schedule and availability.
Norlase has successfully completed a capital increase lead by investment company Capnova and supplemented by our current investors. Capnova’s investment strategy is focused on IT and food-tech, but they chose to partner with Norlase due to the potential of the technology and the strength of the team. Furthermore investment manager Cathal Mahon adds experience in scaling med-tech businesses to the team, as he enters the Norlase board of directors.
The capital increase enables Norlase to live up to the increasing demand for our products, by establishing new production facilities in Roskilde, Denmark. For additional information please reach out at firstname.lastname@example.org
After an exhilarating year, Norlase is now ready to make vital additions to the existing Norlase team.
Are you ready to play a key role in realizing the potential of one of Denmark’s most promising high-tech companies? Are you motivated by taking part in the kind of team spirit that can only be found in a high-growth start-up? Then you might be our new lead engineer.
To see the full job post click here
The Norlase team is pleased to announce a significant seed investment in our company from a danish business angel group consisting of Niels Korsholm, Kalle Hvidt Nielsen and Per Ibsen. This investment will enable Norlase to continue the development and pre-manufacturing phases of our compact laser light source, intended for medical, material processing and other industry applications. David Hardwick, Chairman of Norlase, commented; “Our new partners add both management and egineering skills to our team; as well as their financial investement. We are delighted to have them on board as we head toward the marketplace with our new lasers”
Rasmus Helveg Petersen, minster for Climate, Energy & Building recently visited our offices in the Green Entrepreneur House, along with the mayor of Roskilde and the president of the Danish Technical University.
The minister was particularly interested in the energy-saving potential of Norlase ‘s unique technological platform. CEO Peter Skovgaard introduced our company and explained why Norlase is poised to become Denmarks next green growth success story.
The picture on the right shows Peter presenting our ultra-compact 532.01.02 laser model. From left to right: Norlase CEO Peter Skovgaard, President of DTU Anders Bjarklev, minister for Climate, Energy and Building Rasmus Helveg Petersen, Mayor of Roskilde municipality Joy Mogensen.
A journlist from one of the largest danish newspapers, Berlingske Tidende, has recently visited Norlase to speak to CEO Peter Skovgaard, with the purpose of doing an article about Norlase.
The article has just been published, telling Norlase’s story, while giving an insight into CEO Peter Skovgaard’s ambitious vision for the future.
“My vision simply is to create the worlds best company, producing the worlds best laster. It may sound ambitious, but we have all the potential to do something that resonates internationally.”
The full article can be found in Berlingske Tidende’s business section dated 30/5, or online by following this link.
The Danish Technical University has also done a piece on Norlase recently, focused on how the “Bridging the Gap” innovation model has been key to our success. This article can be found via this link (Danish only).
Norlase has moved its offices out of DTU campus and into the high-tech incubator “Det Grønne Iværksætterhus” (the Green Entrepreneur House).
CEO Peter Skovgaard sees this as another step away from university spin-out and towards full-blown industrial supplier:
“We chose the Green Entrepreneur House as our new address because it fits perfectly with our strategy. Our new offices are both bigger and more modern than what we are used to, but what is really important is that it allows for further expansion of our operations. I am convinced that we have found the perfect place to continue our growth and move Norlase into the next phase.”
The Green Entrepreneur House is located in Risø Huse, conveniently close to DTU Risø. This allows Norlase to continue collaborating with leading researchers. The change of address has entered into force from the beginning of May.
An adventurous journey to San Fransisco is over for the Norlase team. The week got off to a great start, as CEO Peter Skovgaard qualified for the final of the SPIE Startup Challenge, with his 3-minute Norlase pitch. In the final, a strong perfomance earned Norlase a 3rd place in the peoples choice award.
San Fransisco provided the perfect venue for the Norlase launch reception the following evening. We would like to thank the many partners and freinds who showed up to celebrate.
The most important aspect of Photonics West was the constructive talks with a range of interesting industry players. While the conference gave us plenty of joyful memories to look back upon, the interest shown in our products has made us even more keen to look forward!”
The entire Norlase team is attending Photonics West 2014: SPIE Photonics West is the largest and most influential event for the laser and photonics community in North America: 20,000 attendees, two exhibitions, 1,240 exhibiting companies, a wide range of papers on biomedical optics, biophotonics, translational research, industrial lasers, optoelectronics, microfabrication, optical MEMS, and more.
Led by CEO Peter Skovgaard, the Norlase team is traveling 5,500 miles from Copenhagen to San Francisco. If you would like to meet us at PW and hear more about our groundbreaking laser technology and how we can help your company, we can be reached at email@example.com
Norlase has qualified for semi-finals of the SPIE Startup Challenge 2014. This fast-paced pitch competition invites new entrepreneurs to pitch their light-based technology product to a team of business development experts and venture capitalists. Norlase has been chosen among the top 25 teams for the semi-finals in San Fransisco on the 4th of February.
Despite having only 2 slides and 3 minutes to convince the judges, Norlase CEO Peter M. W. Skovgaard believes that his pitch has good chances of taking Norlase to the final. In the final 10.000 USD in cash prices and 5.000 USD in goods is up for grabs. The final is at 3:30 pm on 5th of February in Room 130 of the Moscone Center, San Francisco, California.
Registration for the event is free through www.spie.org.
A business plan for the Norlase technology was entered into the worlds biggest start-up competition, Venture Cup. The entry focused on the potential for Norlase on the market for laser dermatology treatments and was awarded a Booster Pack for being among the teams with the highest potential for growth. The “Booster Pack” secured sponsored goods and services, such as legal and accounting aid, website design and hosting, 500 high-caffeine sodas and more, for a collective value of over 400.000 DKK. Statements from the judges included:
“This is a business plan that addresses all important items. It obvious that this is a very mature team that knows its own strengths and apparently very few weaknesses. It is not easy to come with further recommendations”.
“The product is very clearly described, the team has made good progress and seems to have drive and potential to reach the market”.
“Over all a good plan and very realistic and proffessional approach – Good!”